EUVIMEDEUVIMED entdecken
Crossref

CRISPR-Cas9 in Rare Genetic Disease Treatment: Mechanisms, Applications, and Future Perspectives

Aanchal Sharma

International Journal of Advanced Research in Science Communication and Technology · 23.05.2026 · 118

DOI: 10.48175/ijarsct-35711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Advanced Research in Science Communication and Technology, online erschienen am 23.05.2026. Verfasst von Aanchal Sharma. Die Arbeit nennt 49 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rare genetic diseases are a major challenge for modern medicine due to their heterogeneous etiology, limited therapeutic options, and frequently life-threatening consequences, affecting more than 300 million people worldwide. The emergence of CRISPR-Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR associated protein 9) genome editing technology has revolutionized the field of molecular medicine, providing unprecedented precision and flexibility in modifying the human genome. CRISPR-Cas9 was originally described as a prokaryotic adaptive immune mechanism, that has been adapted into a potent therapeutic tool, capable of correcting disease-causing mutations at the genome level. This review provides a detailed overview of the CRISPR-Cas9 system, including its discovery, molecular structure, principles of guide RNA design, delivery strategies and new variants such as base editors and prime editors. The epidemiology and molecular basis of rare genetic diseases are discussed and conventional treatment modalities such as enzyme replacement therapy, antisense oligonucleotide therapy and viral vector-based gene therapy are critically appraised. This review summarizes the current preclinical and clinical applications of CRISPR-Cas9 in a broad spectrum of rare monogenic disorders including sickle cell disease, beta-thalassemia, Duchenne muscular dystrophy, Huntington's disease, cystic fibrosis, hemophilia A and B, and transthyretin amyloidosis. We also discuss the diagnostic applications of CRISPR including the SHERLOCK and DETECTR platforms. A critical analysis of key challenges including off-target mutagenesis, immunogenicity, delivery barriers and ethical considerations. The review ends with a look to the future of CRISPR-based medicine, toward personalized genomic therapy

Zitieren

APA

Sharma, A. (2026). CRISPR-Cas9 in Rare Genetic Disease Treatment: Mechanisms, Applications, and Future Perspectives. International Journal of Advanced Research in Science Communication and Technology, 118. https://doi.org/10.48175/ijarsct-35711

Vancouver

Sharma A. CRISPR-Cas9 in Rare Genetic Disease Treatment: Mechanisms, Applications, and Future Perspectives. International Journal of Advanced Research in Science Communication and Technology. 2026:118. doi:10.48175/ijarsct-35711

BibTeX
@article{Sharma2026,
  author = {Sharma, Aanchal},
  title = {CRISPR-Cas9 in Rare Genetic Disease Treatment: Mechanisms, Applications, and Future Perspectives},
  journal = {International Journal of Advanced Research in Science Communication and Technology},
  year = {2026},
  pages = {118},
  doi = {10.48175/ijarsct-35711}
}
Kostenlos starten →